1
|
Deloumeaux J, Bhakkan-Mambir B, Desroziers L, Plenet J, Peruvien J, Chatignoux É, Belliardo S, Macni J, Ulric-Gervaise S, Véronique-Baudin J, Joachim C. Urological Cancers in French Overseas Territories: A Population-Based Cancer Registry Pooled Analysis in Martinique, Guadeloupe and French Guiana (2007-2014). J Epidemiol Glob Health 2022; 12:232-238. [PMID: 35041179 PMCID: PMC9470795 DOI: 10.1007/s44197-022-00033-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2021] [Accepted: 01/06/2022] [Indexed: 12/24/2022] Open
Abstract
Purpose Prostate cancer is the most common cancer in the Caribbean. We present world-standardized incidence (WSI) and mortality (WSM) rates for urological cancers for French overseas territories. Materials and Methods Standardized incidence ratio (SIR) and standardized mortality ratio (SMR) were calculated for 2008–2014, 2007–2014 and 2010–2014 in Guadeloupe, Martinique and French Guiana. Results For prostate cancer, in Guadeloupe and Martinique, the WSI rates are among the highest in the world (173.0 and 164.5 per 100,000 person-years) and 94.4 in French Guiana. Mortality remains more than twice that observed in mainland France, at 23.0 in Guadeloupe and Martinique, and 16.9 in French Guiana. For bladder cancer, WSI rates were 5.9, 4.9 and 4.1 in men, and 1.9, 1.4 and 1.3 in women, in French Guiana, Guadeloupe and Martinique. WSM rates from bladder varied from 1.5 in French Guiana to 1.8 in Guadeloupe and 2.0 in Martinique in men. In women, it ranges from 0.2 in French Guiana to 0.5 in Guadeloupe and 1.1 in Martinique. Regarding kidney, WSI rates in men are 4.3 in Martinique, 5.2 in Guadeloupe and 6.1 in French Guiana, and 2.3, 2.5 and 3.4, respectively, in women. Mortality rates in men were 1.7 in Guadeloupe, 1.4 in Martinique, and 1.5 in French Guiana, while in women, rates were 0.8 in Guadeloupe and Martinique and 0.6 in French Guiana. All these rates are lower than in mainland France. Conclusions Identifying the profile of patients with urological cancers is key to understanding the needs of patients in these regions.
Collapse
Affiliation(s)
- Jacqueline Deloumeaux
- Registre Général des Cancers de Guadeloupe, Centre Hospitalier Universitaire de Guadeloupe, Guadeloupe F.W. I., Route de Chauvel, 97159 Pointe-à-Pitre Cedex, France
| | - Bernard Bhakkan-Mambir
- Registre Général des Cancers de Guadeloupe, Centre Hospitalier Universitaire de Guadeloupe, Guadeloupe F.W. I., Route de Chauvel, 97159 Pointe-à-Pitre Cedex, France
| | | | | | - Jessica Peruvien
- Registre Général des Cancers de Guadeloupe, Centre Hospitalier Universitaire de Guadeloupe, Guadeloupe F.W. I., Route de Chauvel, 97159 Pointe-à-Pitre Cedex, France
| | - Édouard Chatignoux
- French National Public Health Agency, 12 rue du Val d’Osne, 94410 Saint Maurice, France
| | | | - Jonathan Macni
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre Général des Cancers de la Martinique, Fort de France, 97200 Martinique
| | - Stephen Ulric-Gervaise
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre Général des Cancers de la Martinique, Fort de France, 97200 Martinique
| | - Jacqueline Véronique-Baudin
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre Général des Cancers de la Martinique, Fort de France, 97200 Martinique
| | - Clarisse Joachim
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre Général des Cancers de la Martinique, Fort de France, 97200 Martinique
- Hôpital Albert Clarac, Avenue Pasteur, CS 90632, 97200 Fort de France, Martinique
| |
Collapse
|
2
|
Joachim C, Almont T, Drame M, Contaret C, Vestris M, Najioullah F, Aline-Fardin A, Escarmant P, Leduc N, Grossat N, Promeyrat X, Bougas S, Papadopoulou E, Vinh-Hung V, Sylvestre E, Veronique-Baudin J. International cooperation in public health in Martinique: geostrategic utility for cancer surveillance in the Caribbean. Global Health 2020; 16:20. [PMID: 32131844 PMCID: PMC7057621 DOI: 10.1186/s12992-020-00551-w] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 02/20/2020] [Indexed: 12/14/2022] Open
Abstract
Background Cooperation in public health and in oncology in particular, is currently a major issue for the island of Martinique, given its geopolitical position in the Caribbean region. The region of Martinique shares certain public health problems with other countries of the Caribbean, notably in terms of diagnostic and therapeutic management of patients with cancer. We present here a roadmap of cooperation priorities and activities in cancer surveillance and oncology in Martinique. Main body The fight against cancer is a key public health priority that features high on the regional health policy for Martinique. In the face of these specific epidemiological conditions, Martinique needs to engage in medical cooperation in the field of oncology within the Caribbean, to improve skills and knowledge in this field, and to promote the creation of bilateral relations that will help to improve cancer management in an international healthcare environment. Conclusions These collaborative exchanges will continue throughout 2020 and will lead to the implementation of mutual research projects across a larger population basin, integrating e-health approaches and epidemiological e-cohorts.
Collapse
Affiliation(s)
- Clarisse Joachim
- , CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre des cancers, Martinique, F-97200, France.
| | - Thierry Almont
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF3636 INTERREG Surveillance du Cancer Oncofertilité, F-97200, Martinique, France
| | - Moustapha Drame
- CHU de Martinique, Direction de la Recherche, UF 3603, Unité de Soutien Méthodologique à la Recherche, Martinique, F-97200, France
| | - Cédric Contaret
- CHU de Martinique, Direction de la Recherche, UF 3163, Délégation de la Recherche et de l'innovation, Martinique, F-97200, France
| | - Mylène Vestris
- , CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 1441 Registre des cancers, Martinique, F-97200, France
| | - Fatiha Najioullah
- CHU de Martinique, Pôle de Biologie, Laboratoire de Virologie, F-97200, Martinique, France
| | - Aude Aline-Fardin
- CHU de Martinique, Pôle de Biologie, Laboratoire d'anatomopathologie, F-97200, Martinique, France
| | - Patrick Escarmant
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Nicolas Leduc
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Nathalie Grossat
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Xavier Promeyrat
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Stefanos Bougas
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Eva Papadopoulou
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Vincent Vinh-Hung
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, F-97200, Martinique, France
| | - Emmanuelle Sylvestre
- CHU de Martinique, Centre de Données Cliniques, F-97200, Martinique, France.,CHU de Martinique, Pôle de Médecine, Service de Maladies Infectieuses, F-97200, Martinique, France.,INSERM, U1099, F-35000, Rennes, France.,Université de Rennes 1, LTSI, F-35000, Rennes, France
| | - Jacqueline Veronique-Baudin
- CHU de Martinique, Pôle de Cancérologie Hématologie Urologie, UF 3596 Recherche en Cancérologie Hématologie, F-97200, Martinique, France
| |
Collapse
|